{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:58Z","timestamp":1786982758956,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s40265-020-01344-6","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T08:02:21Z","timestamp":1593072141000},"page":"1101-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-7831","authenticated-orcid":false,"given":"Arnold","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"5","key":"1344_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/09286586.2012.698692","volume":"19","author":"OD Schein","year":"2012","unstructured":"Schein OD, Cassard SD, Tielsch JM, et al. Cataract surgery among Medicare beneficiaries. Ophthalmic Epidemiol. 2012;19(5):257\u201364.","journal-title":"Ophthalmic Epidemiol"},{"key":"1344_CR2","unstructured":"American Academy of Ophthalmology. Eye Health Statistics. https:\/\/www.aao.org\/. Accessed 19 May 2020."},{"issue":"12 Suppl","key":"1344_CR3","first-page":"S215","volume":"25","author":"CL Salinger","year":"2019","unstructured":"Salinger CL, Gaynes BI, Rajpal RK. Innovations in topical ocular corticosteroid therapy for the management of postoperative ocular inflammation and pain. Am J Manag Care. 2019;25(12 Suppl):S215\u2013S226226.","journal-title":"Am J Manag Care"},{"key":"1344_CR4","first-page":"1","volume":"2018","author":"S Wu","year":"2018","unstructured":"Wu S, Tong N, Pan L, et al. Retrospective analyses of potential risk factors for posterior capsule opacification after cataract surgery. J Ophthalmol. 2018;2018:1\u20137.","journal-title":"J Ophthalmol"},{"issue":"6","key":"1344_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archophthalmol.2009.96","volume":"127","author":"JL Stone","year":"2009","unstructured":"Stone JL. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol. 2009;127(6):732.","journal-title":"Arch Ophthalmol"},{"key":"1344_CR6","unstructured":"Ocular Therapeutix. DEXTENZA\u00ae (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use: US prescribing information. 2019. https:\/\/www.dextenza.com\/. Accessed 19 May 2020."},{"issue":"16","key":"1344_CR7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711\u201323.","journal-title":"N Engl J Med"},{"key":"1344_CR8","unstructured":"Center for Drug Evaluation and Research. Clinical pharmacology and biopharmaceutics review(s) (208742Orig1s000). 2016. https:\/\/www.accessdata.fda.gov\/. Accessed 19 May 2019."},{"key":"1344_CR9","unstructured":"Bafna S, Wortz G, Walters T, et al. Retention of Dextenza (dexamethasone intracanalicular insert), a sustained-release corticosteroid in phase 3 clinical trial program [abstract no. PO003 plus presentation]. In: American Academy of Ophthalmology Annual Meeting. 2019."},{"issue":"13","key":"1344_CR10","first-page":"472","volume":"55","author":"M McGrath","year":"2014","unstructured":"McGrath M, Blizzard CD, Desai A, et al. In vivo drug delivery of low solubility drugs from biodegradable hydrogel punctum plugs [abstract plus poster]. Investig Ophthalmol Vis Sci. 2014;55(13):472.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"1344_CR11","first-page":"238","volume":"56","author":"A Vanslette","year":"2015","unstructured":"Vanslette A, McGrath M, O'Connor M, et al. Dose based pharmacokinetics of sustained release dexamethasone in beagles [abstract plus poster]. Investig Ophthalmol Vis Sci. 2015;56(7):238.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"1344_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2155-9570.1000572","volume":"7","author":"T Walters","year":"2016","unstructured":"Walters T, Bafna S, Vold S, et al. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies. J Clin Exp Ophthalmol. 2016;7(4):1\u201311.","journal-title":"J Clin Exp Ophthalmol"},{"issue":"2","key":"1344_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcrs.2018.09.023","volume":"45","author":"SL Tyson","year":"2019","unstructured":"Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204\u201312.","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"1344_CR14","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jcrs.2015.11.005","volume":"41","author":"T Walters","year":"2015","unstructured":"Walters T, Endl M, Elmer TR, et al. Sustained-release dexamethasone for the treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2015;41(10):2049\u201359.","journal-title":"J Cataract Refract Surg"},{"key":"1344_CR15","unstructured":"Hovanesian JA, Tyson SL, Walters T, et al. Differences in postsurgical pain and inflammation outcome of patients receiving dexamethasone insert (Dextenza) based on fellow eye lens status [abstract no. PA024 plus presentation]. In: American Academy of Ophthalmology Annual Meeting. 2019."},{"key":"1344_CR16","unstructured":"Center for Drug Evaluation and Research. Statistical review(s) (208742Orig1s000). 2016. https:\/\/www.accessdata.fda.gov\/. Accessed 19 May 2020."},{"key":"1344_CR17","unstructured":"Ocular Therapeutix. Data on file. 2015."},{"key":"1344_CR18","unstructured":"Noecker R, Hovanesian JA, Walters T, et al. Evaluating the physician and patient experience of a dexamethasone insert (0.4 mg) in patients having cataract surgery [oral presentation]. In: American Society of Cataract and Refractive Surgery. 2018."},{"key":"1344_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/PPA.S126283","volume":"11","author":"JP Gira","year":"2017","unstructured":"Gira JP, Sampson R, Silverstein SM, et al. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487\u201394.","journal-title":"Patient Prefer Adherence"},{"key":"1344_CR20","unstructured":"Tyson SL, Bafna S, Berdahl JP, et al. Management of ocular inflammation and pain following cataract surgery with 0.4 mg dexamethasone insert [abstract plus presentation]. In: American Society of Cataract and Refractive Surgery\/American Society of Ophthalmic Administrators Annual Meeting. 2019"},{"key":"1344_CR21","unstructured":"Hovanesian JA, Berdahl JP, Mah FS, et al. Integrated analysis of a dexamethasone insert (0.4 mg) for the treatment of ocular pain after cataract surgery [abstract no. PO295 plus poster]. In: American Academy of Ophthalmology Annual Meeting. 2017."},{"issue":"2","key":"1344_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","volume":"11","author":"S Phulke","year":"2017","unstructured":"Phulke S, Kaushik S, Kaur S, et al. Steroid-induced glaucoma: an avoidable irreversible blindness. J Curr Glaucoma Pract. 2017;11(2):67\u201372.","journal-title":"J Curr Glaucoma Pract"},{"key":"1344_CR23","unstructured":"Vantipalli S, Metzinger JL, Goldstein MH. Intraocular pressure effects of DEXTENZA\u00ae (dexamethasone ophthalmic insert, 0.4 mg), a novel sustained release steroid delivery via an intracanalicular insert, for treating post-cataract inflammation and pain [abstract plus presentation]. In: 3rd World Congress of Optometry. 2019"},{"issue":"9","key":"1344_CR24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.jcrs.2016.06.006","volume":"42","author":"RS Hoffman","year":"2016","unstructured":"Hoffman RS, Braga-Mele R, Donaldson K, et al. Cataract surgery and nonsteroidal antiinflammatory drugs. J Cataract Refract Surg. 2016;42(9):1368\u201379.","journal-title":"J Cataract Refract Surg"},{"key":"1344_CR25","unstructured":"EyePoint Pharmaceuticals. DEXYCU intraocular dexamethasone suspension: US prescribing information. 2018. https:\/\/dexycu.com\/. Accessed 19 May 2020."},{"issue":"2","key":"1344_CR26","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2016.09.027","volume":"124","author":"RJ Olson","year":"2017","unstructured":"Olson RJ, Braga-Mele R, Chen SH, et al. Cataract in the adult eye preferred practice pattern. Ophthalmology. 2017;124(2):P1\u2013P119.","journal-title":"Ophthalmology"},{"key":"1344_CR27","first-page":"CD010516","volume":"7","author":"VV Juthani","year":"2017","unstructured":"Juthani VV, Clearfield E, Chuck RS. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Cochrane Database Syst Rev. 2017;7:CD010516.","journal-title":"Cochrane Database Syst Rev"},{"key":"1344_CR28","unstructured":"American Society of Cataract and Refractive Surgery. ASCRS Clinical Survey 2017. https:\/\/supplements.eyeworld.org\/. Accessed 19 May 2020."},{"key":"1344_CR29","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.2147\/OPTH.S165722","volume":"12","author":"TJ Shah","year":"2018","unstructured":"Shah TJ, Conway MD, Peyman GA. Intracameral dexamethasone injection in the treatment of cataract surgery induced inflammation: design, development, and place in therapy. Clin Ophthalmol. 2018;12:2223\u201335.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1344_CR30","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jcrs.2019.02.016","volume":"45","author":"SL Tyson","year":"2019","unstructured":"Tyson SL, Bafna S, Gira JP, et al. Reply to: Grzybowski A, Kanclerz P. Benefits of noninferiority studies in ophthalmology. J Cataract Refract Surg. 2019;45(4):534\u20135.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"1344_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/02713683.2013.841258","volume":"39","author":"AM Alfawaz","year":"2013","unstructured":"Alfawaz AM, Algehedan S, Jastaneiah SS, et al. Efficacy of punctal occlusion in management of dry eyes after laser in situ keratomileusis for myopia. Curr Eye Res. 2013;39(3):257\u201362.","journal-title":"Curr Eye Res"},{"issue":"2","key":"1344_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jtos.2015.12.004","volume":"14","author":"L Tong","year":"2016","unstructured":"Tong L, Beuerman R, Simonyi S, et al. Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye. Ocul Surf. 2016;14(2):233\u201341.","journal-title":"Ocul Surf"},{"issue":"3","key":"1344_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0928-0987(97)00082-1","volume":"6","author":"N Esmailpour","year":"1998","unstructured":"Esmailpour N, H\u00f6gger P, Rohdewald P. Binding kinetics of budesonide to the human glucocorticoid receptor. Eur J Pharm Sci. 1998;6(3):219\u201323.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"1344_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/jop.2016.0025","volume":"32","author":"C Blizzard","year":"2016","unstructured":"Blizzard C, Desai A, Driscoll A. Pharmacokinetic studies of sustained-release depot of dexamethasone in beagle dogs. J Ocul Pharmacol Ther. 2016;32(9):595\u2013600.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"1344_CR35","first-page":"4106","volume":"58","author":"EB McLaurin","year":"2017","unstructured":"McLaurin EB, Evans DG, Noecker R, et al. A single center study of the plasma pharmacokinetics of DEXTENZA (dexamethasone insert) 0.4 mg in healthy volunteers [abstract no. 4106 plus poster]. Investig Ophthalmol Vis Sci. 2017;58(8):4106.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"1344_CR36","unstructured":"Ibach M, Metzinger JL, Vantipalli S, et al. Patient preference and physician experience with DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, a novel sustained-release intracanalicular insert for the treatment of postoperative pain and inflammation following cataract surgery [abstract plus poster]. In: 3rd World Congress of Optometry. 2019"}],"updated-by":[{"DOI":"10.1007\/s40265-020-01366-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000}}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-020-01344-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-020-01344-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-020-01344-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T19:27:10Z","timestamp":1626722830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-020-01344-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s40265-020-01344-6","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"20 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article Dexamethasone Intracanalicular Insert: A Review in Treating Post-Surgical Ocular Pain and Inflammation, written by Arnold Lee and Hannah A. Blair, was originally published electronically in SpringerLink on 25 June 2020 without Open Access.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Arnold Lee and Hannah Blair are salaried employees of Adis International Ltd\/Springer Nature, are responsible for the article content and declare no relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}